Skip to main content

Table 1 The diagnostic values of EGFR plasma test between groups

From: Smoking habit and chemo-radiotherapy and/or surgery affect the sensitivity of EGFR plasma test in non-small cell lung cancer

Variable

Concordance

Sensitivity

Specificity

Percentage (%)

P-value

Percentage (%)

P-value

Percentage (%)

P-value

Mutation type

 EGFRE19del (n = 125)

92.8

0.212

77.5

0.472

100.0

0.360

 EGFRL858R (n = 125)

95.2

 

78.2

 

99.0

 

Age

 ≥ 59 (n = 57)

87.7

0.694

79.3

0.510

96.4

0.467

 < 59 (n = 68)

85.3

 

72.2

 

100.0

 

Gender

 Female (n = 37)

83.8

0.290

80.0

0.424

100.0

0.714

 Male (n = 88)

87.5

 

71.4

 

98.1

 

Ecog PS

 0–1 (n = 101)

84.2

0.191

70.6

0.159

98.0

0.833

 ≥ 2 (n = 24)

95.8

 

92.9

 

100.0

 

Smoking status

 No (n = 54)

87.0

0.428

84.1

0.018

100.0

0.652

 Yes (n = 71)

85.9

 

57.1

 

98.0

 

Clinical stage

 IIIB (n = 6)

83.3

0.592

66.7

0.578

100.0

0.950

 IV (n = 119)

86.6

 

75.8

 

98.3

 

Lung metastasis

 No (n = 86)

84.9

0.334

73.3

0.404

97.6

0.683

 Yes (n = 39)

89.7

 

80.0

 

100.0

 

Lymph-node

 No (n = 42)

85.7

0.874

75.0

0.956

100.0

0.700

 Yes (n = 83)

86.8

 

75.6

 

97.6

 

Pleural effusion

 No (n = 86)

83.7

0.155

70.5

0.152

97.6

0.700

 Yes (n = 39)

92.3

 

85.7

 

100.0

 

Distant metastasis

 No (n = 25)

88.0

0.545

80.0

0.461

100.0

0.833

 Yes (n = 100)

86.0

 

74.0

 

98.0

 

 Tumor size

 ≤ 5 cm (n = 43)

84.2

0.233

70.0

0.164

97.0

0.700

 > 5 cm (n = 82)

90.7

 

84.0

 

100.0

 

Treatment: chemo-radiotherapy and/or surgery

 No (n = 69)

91.3

0.076

85.7

0.009

100.0

0.362

 Yes (n = 56)

80.4

 

56.5

 

97.0

 

Treatment/Smoking status

 No/No (n = 34)

91.2

0.418

90.3

0.004

100.0

0.483

 No/Yes or Yes/No (n = 55)

87.3

 

70.8

 

100.0

 

 Yes/Yes (n = 36)

80.6

 

40.0

 

96.2

 
  1. Significant values are shown in italic